カテゴリ：世界, 医療/バイオ, QYResearch

ファンコニ貧血治療の世界市場インサイト・予測（～2028年）

■ 英語タイトル：Global Fanconi Anemia Treatment Market Insights, Forecast to 2028
	■ 発行会社/調査会社：QYResearch ■ 商品コード：QY22JL3459 ■ 発行日：2022年7月（※2025年版があります。お問い合わせください。） ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：125 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ファンコニ貧血治療の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

COVID-19のパンデミックにより、ファンコニ貧血治療のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にファンコニ貧血治療の世界市場のxxx％を占める「血液骨髄移植」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「クリニック」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ファンコニ貧血治療の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのファンコニ貧血治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ファンコニ貧血治療のグローバル主要企業には、Allergan、Merck、Pfizer、GlaxoSmithKline、Melinta Therapeutics、Basilea Pharmaceutica、Tetraphase Pharmaceuticals、Paratek Pharmaceuticals、Nabriva Therapeutics、Spero Therapeutics、Abbott、F. Hoffmann-La Roche、Mylan N.V.、Teva Pharmaceutical Industries、Sanofi、Novartis、Bayer、Sun Pharmaceutical Industries、Aurobindo Pharma、Lupin、SHIONOGI、AbbVie、Eli Lillyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ファンコニ貧血治療市場は、種類と用途によって区分されます。世界のファンコニ貧血治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
血液骨髄移植、輸血、医薬品、その他

【用途別セグメント】
クリニック、病院、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ファンコニ貧血治療製品概要
- 種類別市場（血液骨髄移植、輸血、医薬品、その他）
- 用途別市場（クリニック、病院、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のファンコニ貧血治療販売量予測2017-2028
- 世界のファンコニ貧血治療売上予測2017-2028
- ファンコニ貧血治療の地域別販売量
- ファンコニ貧血治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ファンコニ貧血治療販売量
- 主要メーカー別ファンコニ貧血治療売上
- 主要メーカー別ファンコニ貧血治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（血液骨髄移植、輸血、医薬品、その他）
- ファンコニ貧血治療の種類別販売量
- ファンコニ貧血治療の種類別売上
- ファンコニ貧血治療の種類別価格
・用途別市場規模（クリニック、病院、その他）
- ファンコニ貧血治療の用途別販売量
- ファンコニ貧血治療の用途別売上
- ファンコニ貧血治療の用途別価格
・北米市場
- 北米のファンコニ貧血治療市場規模（種類別、用途別）
- 主要国別のファンコニ貧血治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのファンコニ貧血治療市場規模（種類別、用途別）
- 主要国別のファンコニ貧血治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のファンコニ貧血治療市場規模（種類別、用途別）
- 主要国別のファンコニ貧血治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のファンコニ貧血治療市場規模（種類別、用途別）
- 主要国別のファンコニ貧血治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのファンコニ貧血治療市場規模（種類別、用途別）
- 主要国別のファンコニ貧血治療市場規模（トルコ、サウジアラビア）
・企業情報
Allergan、Merck、Pfizer、GlaxoSmithKline、Melinta Therapeutics、Basilea Pharmaceutica、Tetraphase Pharmaceuticals、Paratek Pharmaceuticals、Nabriva Therapeutics、Spero Therapeutics、Abbott、F. Hoffmann-La Roche、Mylan N.V.、Teva Pharmaceutical Industries、Sanofi、Novartis、Bayer、Sun Pharmaceutical Industries、Aurobindo Pharma、Lupin、SHIONOGI、AbbVie、Eli Lilly
・産業チェーン及び販売チャネル分析
- ファンコニ貧血治療の産業チェーン分析
- ファンコニ貧血治療の原材料
- ファンコニ貧血治療の生産プロセス
- ファンコニ貧血治療の販売及びマーケティング
- ファンコニ貧血治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ファンコニ貧血治療の産業動向
- ファンコニ貧血治療のマーケットドライバー
- ファンコニ貧血治療の課題
- ファンコニ貧血治療の阻害要因
・主な調査結果

Fanconi anemia is an autosomal recessive illness marked by impaired haemopoiesis, congenital anomalies, and a significant incidence of solid tumors and acute myeloid leukaemia in patients. It is a rare disease that affects the bone marrow and is handed down via families (inherited). Fanconi anemia is indicated by shortness of breath, frequent nasal bleeding, weariness, recurring viral infection and cold, low stature and poor growth are all indications of fanconi anemia.
Market Analysis and Insights: Global Fanconi Anemia Treatment Market
The global Fanconi Anemia Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Blood and Bone Marrow Transplant accounting for % of the Fanconi Anemia Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Clinic segment is altered to an % CAGR throughout this forecast period.
China Fanconi Anemia Treatment market size is valued at US$ million in 2021, while the North America and Europe Fanconi Anemia Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fanconi Anemia Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fanconi Anemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fanconi Anemia Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fanconi Anemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fanconi Anemia Treatment market.
Global Fanconi Anemia Treatment Scope and Market Size
Fanconi Anemia Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Fanconi Anemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Blood and Bone Marrow Transplant
Blood Transfusion
Medication
Others
Segment by Application
Clinic
Hospital
Others
By Company
Allergan
Merck
Pfizer
GlaxoSmithKline
Melinta Therapeutics
Basilea Pharmaceutica
Tetraphase Pharmaceuticals
Paratek Pharmaceuticals
Nabriva Therapeutics
Spero Therapeutics
Abbott
F. Hoffmann-La Roche
Mylan N.V.
Teva Pharmaceutical Industries
Sanofi
Novartis
Bayer
Sun Pharmaceutical Industries
Aurobindo Pharma
Lupin
SHIONOGI
AbbVie
Eli Lilly
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

*** レポート目次（コンテンツ）***

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fanconi Anemia Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood and Bone Marrow Transplant
1.2.3 Blood Transfusion
1.2.4 Medication
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fanconi Anemia Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fanconi Anemia Treatment Market Perspective (2017-2028)
2.2 Fanconi Anemia Treatment Growth Trends by Region
2.2.1 Fanconi Anemia Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fanconi Anemia Treatment Historic Market Size by Region (2017-2022)
2.2.3 Fanconi Anemia Treatment Forecasted Market Size by Region (2023-2028)
2.3 Fanconi Anemia Treatment Market Dynamics
2.3.1 Fanconi Anemia Treatment Industry Trends
2.3.2 Fanconi Anemia Treatment Market Drivers
2.3.3 Fanconi Anemia Treatment Market Challenges
2.3.4 Fanconi Anemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fanconi Anemia Treatment Players by Revenue
3.1.1 Global Top Fanconi Anemia Treatment Players by Revenue (2017-2022)
3.1.2 Global Fanconi Anemia Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Fanconi Anemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fanconi Anemia Treatment Revenue
3.4 Global Fanconi Anemia Treatment Market Concentration Ratio
3.4.1 Global Fanconi Anemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fanconi Anemia Treatment Revenue in 2021
3.5 Fanconi Anemia Treatment Key Players Head office and Area Served
3.6 Key Players Fanconi Anemia Treatment Product Solution and Service
3.7 Date of Enter into Fanconi Anemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fanconi Anemia Treatment Breakdown Data by Type
4.1 Global Fanconi Anemia Treatment Historic Market Size by Type (2017-2022)
4.2 Global Fanconi Anemia Treatment Forecasted Market Size by Type (2023-2028)
5 Fanconi Anemia Treatment Breakdown Data by Application
5.1 Global Fanconi Anemia Treatment Historic Market Size by Application (2017-2022)
5.2 Global Fanconi Anemia Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fanconi Anemia Treatment Market Size (2017-2028)
6.2 North America Fanconi Anemia Treatment Market Size by Type
6.2.1 North America Fanconi Anemia Treatment Market Size by Type (2017-2022)
6.2.2 North America Fanconi Anemia Treatment Market Size by Type (2023-2028)
6.2.3 North America Fanconi Anemia Treatment Market Share by Type (2017-2028)
6.3 North America Fanconi Anemia Treatment Market Size by Application
6.3.1 North America Fanconi Anemia Treatment Market Size by Application (2017-2022)
6.3.2 North America Fanconi Anemia Treatment Market Size by Application (2023-2028)
6.3.3 North America Fanconi Anemia Treatment Market Share by Application (2017-2028)
6.4 North America Fanconi Anemia Treatment Market Size by Country
6.4.1 North America Fanconi Anemia Treatment Market Size by Country (2017-2022)
6.4.2 North America Fanconi Anemia Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Fanconi Anemia Treatment Market Size (2017-2028)
7.2 Europe Fanconi Anemia Treatment Market Size by Type
7.2.1 Europe Fanconi Anemia Treatment Market Size by Type (2017-2022)
7.2.2 Europe Fanconi Anemia Treatment Market Size by Type (2023-2028)
7.2.3 Europe Fanconi Anemia Treatment Market Share by Type (2017-2028)
7.3 Europe Fanconi Anemia Treatment Market Size by Application
7.3.1 Europe Fanconi Anemia Treatment Market Size by Application (2017-2022)
7.3.2 Europe Fanconi Anemia Treatment Market Size by Application (2023-2028)
7.3.3 Europe Fanconi Anemia Treatment Market Share by Application (2017-2028)
7.4 Europe Fanconi Anemia Treatment Market Size by Country
7.4.1 Europe Fanconi Anemia Treatment Market Size by Country (2017-2022)
7.4.2 Europe Fanconi Anemia Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fanconi Anemia Treatment Market Size (2017-2028)
8.2 Asia-Pacific Fanconi Anemia Treatment Market Size by Type
8.2.1 Asia-Pacific Fanconi Anemia Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Fanconi Anemia Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Fanconi Anemia Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Fanconi Anemia Treatment Market Size by Application
8.3.1 Asia-Pacific Fanconi Anemia Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Fanconi Anemia Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Fanconi Anemia Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Fanconi Anemia Treatment Market Size by Region
8.4.1 Asia-Pacific Fanconi Anemia Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Fanconi Anemia Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fanconi Anemia Treatment Market Size (2017-2028)
9.2 Latin America Fanconi Anemia Treatment Market Size by Type
9.2.1 Latin America Fanconi Anemia Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Fanconi Anemia Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Fanconi Anemia Treatment Market Share by Type (2017-2028)
9.3 Latin America Fanconi Anemia Treatment Market Size by Application
9.3.1 Latin America Fanconi Anemia Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Fanconi Anemia Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Fanconi Anemia Treatment Market Share by Application (2017-2028)
9.4 Latin America Fanconi Anemia Treatment Market Size by Country
9.4.1 Latin America Fanconi Anemia Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Fanconi Anemia Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fanconi Anemia Treatment Market Size (2017-2028)
10.2 Middle East & Africa Fanconi Anemia Treatment Market Size by Type
10.2.1 Middle East & Africa Fanconi Anemia Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Fanconi Anemia Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Fanconi Anemia Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Fanconi Anemia Treatment Market Size by Application
10.3.1 Middle East & Africa Fanconi Anemia Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Fanconi Anemia Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Fanconi Anemia Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Fanconi Anemia Treatment Market Size by Country
10.4.1 Middle East & Africa Fanconi Anemia Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Fanconi Anemia Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Fanconi Anemia Treatment Introduction
11.1.4 Allergan Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.1.5 Allergan Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Fanconi Anemia Treatment Introduction
11.2.4 Merck Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Fanconi Anemia Treatment Introduction
11.3.4 Pfizer Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Fanconi Anemia Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Melinta Therapeutics
11.5.1 Melinta Therapeutics Company Details
11.5.2 Melinta Therapeutics Business Overview
11.5.3 Melinta Therapeutics Fanconi Anemia Treatment Introduction
11.5.4 Melinta Therapeutics Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.5.5 Melinta Therapeutics Recent Developments
11.6 Basilea Pharmaceutica
11.6.1 Basilea Pharmaceutica Company Details
11.6.2 Basilea Pharmaceutica Business Overview
11.6.3 Basilea Pharmaceutica Fanconi Anemia Treatment Introduction
11.6.4 Basilea Pharmaceutica Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.6.5 Basilea Pharmaceutica Recent Developments
11.7 Tetraphase Pharmaceuticals
11.7.1 Tetraphase Pharmaceuticals Company Details
11.7.2 Tetraphase Pharmaceuticals Business Overview
11.7.3 Tetraphase Pharmaceuticals Fanconi Anemia Treatment Introduction
11.7.4 Tetraphase Pharmaceuticals Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.7.5 Tetraphase Pharmaceuticals Recent Developments
11.8 Paratek Pharmaceuticals
11.8.1 Paratek Pharmaceuticals Company Details
11.8.2 Paratek Pharmaceuticals Business Overview
11.8.3 Paratek Pharmaceuticals Fanconi Anemia Treatment Introduction
11.8.4 Paratek Pharmaceuticals Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.8.5 Paratek Pharmaceuticals Recent Developments
11.9 Nabriva Therapeutics
11.9.1 Nabriva Therapeutics Company Details
11.9.2 Nabriva Therapeutics Business Overview
11.9.3 Nabriva Therapeutics Fanconi Anemia Treatment Introduction
11.9.4 Nabriva Therapeutics Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.9.5 Nabriva Therapeutics Recent Developments
11.10 Spero Therapeutics
11.10.1 Spero Therapeutics Company Details
11.10.2 Spero Therapeutics Business Overview
11.10.3 Spero Therapeutics Fanconi Anemia Treatment Introduction
11.10.4 Spero Therapeutics Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.10.5 Spero Therapeutics Recent Developments
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Fanconi Anemia Treatment Introduction
11.11.4 Abbott Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.11.5 Abbott Recent Developments
11.12 F. Hoffmann-La Roche
11.12.1 F. Hoffmann-La Roche Company Details
11.12.2 F. Hoffmann-La Roche Business Overview
11.12.3 F. Hoffmann-La Roche Fanconi Anemia Treatment Introduction
11.12.4 F. Hoffmann-La Roche Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.12.5 F. Hoffmann-La Roche Recent Developments
11.13 Mylan N.V.
11.13.1 Mylan N.V. Company Details
11.13.2 Mylan N.V. Business Overview
11.13.3 Mylan N.V. Fanconi Anemia Treatment Introduction
11.13.4 Mylan N.V. Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.13.5 Mylan N.V. Recent Developments
11.14 Teva Pharmaceutical Industries
11.14.1 Teva Pharmaceutical Industries Company Details
11.14.2 Teva Pharmaceutical Industries Business Overview
11.14.3 Teva Pharmaceutical Industries Fanconi Anemia Treatment Introduction
11.14.4 Teva Pharmaceutical Industries Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.14.5 Teva Pharmaceutical Industries Recent Developments
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Fanconi Anemia Treatment Introduction
11.15.4 Sanofi Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.15.5 Sanofi Recent Developments
11.16 Novartis
11.16.1 Novartis Company Details
11.16.2 Novartis Business Overview
11.16.3 Novartis Fanconi Anemia Treatment Introduction
11.16.4 Novartis Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.16.5 Novartis Recent Developments
11.17 Bayer
11.17.1 Bayer Company Details
11.17.2 Bayer Business Overview
11.17.3 Bayer Fanconi Anemia Treatment Introduction
11.17.4 Bayer Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.17.5 Bayer Recent Developments
11.18 Sun Pharmaceutical Industries
11.18.1 Sun Pharmaceutical Industries Company Details
11.18.2 Sun Pharmaceutical Industries Business Overview
11.18.3 Sun Pharmaceutical Industries Fanconi Anemia Treatment Introduction
11.18.4 Sun Pharmaceutical Industries Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.18.5 Sun Pharmaceutical Industries Recent Developments
11.19 Aurobindo Pharma
11.19.1 Aurobindo Pharma Company Details
11.19.2 Aurobindo Pharma Business Overview
11.19.3 Aurobindo Pharma Fanconi Anemia Treatment Introduction
11.19.4 Aurobindo Pharma Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.19.5 Aurobindo Pharma Recent Developments
11.20 Lupin
11.20.1 Lupin Company Details
11.20.2 Lupin Business Overview
11.20.3 Lupin Fanconi Anemia Treatment Introduction
11.20.4 Lupin Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.20.5 Lupin Recent Developments
11.21 SHIONOGI
11.21.1 SHIONOGI Company Details
11.21.2 SHIONOGI Business Overview
11.21.3 SHIONOGI Fanconi Anemia Treatment Introduction
11.21.4 SHIONOGI Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.21.5 SHIONOGI Recent Developments
11.22 AbbVie
11.22.1 AbbVie Company Details
11.22.2 AbbVie Business Overview
11.22.3 AbbVie Fanconi Anemia Treatment Introduction
11.22.4 AbbVie Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.22.5 AbbVie Recent Developments
11.23 Eli Lilly
11.23.1 Eli Lilly Company Details
11.23.2 Eli Lilly Business Overview
11.23.3 Eli Lilly Fanconi Anemia Treatment Introduction
11.23.4 Eli Lilly Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.23.5 Eli Lilly Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

ファンコニ貧血治療の世界市場インサイト・予測（～2028年）

グローバル市場調査会社